UK markets open in 5 hours 4 minutes
NIKKEI 225
38,800.45 -99.57 (-0.26%) HANG SENG
18,834.88 +7.53 (+0.04%) CRUDE OIL
78.77 +1.05 (+1.35%) GOLD FUTURES
2,356.50 +22.00 (+0.94%) DOW
39,069.59 +4.29 (+0.01%) Bitcoin GBP
53,748.25 -321.94 (-0.60%)
Catalent, Inc. (CTLT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 54.65 |
| Open | 54.70 |
| Bid | 54.08 x 800 |
| Ask | 56.34 x 1000 |
| Day's range | 54.70 - 55.18 |
| 52-week range | 31.80 - 60.20 |
| Volume | |
| Avg. volume | 1,810,972 |
| Market cap | 9.921B |
| Beta (5Y monthly) | 1.18 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.48 |
| Earnings date | 27 Aug 2024 - 02 Sept 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 56.70 |
ZacksCatalent's (CTLT) Latest Partnership to Boost Clinical Trials
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
ZacksCatalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
GuruFocus.comDecoding Catalent Inc (CTLT): A Strategic SWOT Insight
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats
© 2024 Yahoo. All rights reserved.